May 08, 2018

Schumer, Gillibrand Announce Nearly $500,000 In Federal Funds For Binghamton University

Funding Will Be Used to Support Research of Cell Development and Neuromuscular Defects

Washington, DC – U.S. Senate Minority Leader Charles E. Schumer and U.S. Senator Kirsten Gillibrand today announced $448,607.00 in federal funding for Binghamton University. The funding was allocated through Health and Human Services’ (HHS) National Institute of General Medical Sciences (NIGMS). The funding will be used to support researchers at Binghamton University and their important efforts in studying how cells develop in order to help prevent defects from occurring during cell replication. Specifically, this federal grant will fund research into causes of neuromuscular and brain development diseases and possible therapies for these conditions.

“This critical federal investment is great news for the world-class scientists at Binghamton University, who work tirelessly to produce cutting-edge research on cell growth and development," said Senator Schumer. “Binghamton University is home to some of New York State’s brightest and continues to be a leader in scientific research. With this vital funding, the university can continue to produce innovative findings of national significance, and I will continue to fight for funding that invests in New York State’s universities and scientists who can make a real difference in the future of groundbreaking scientific developments.”

“This federal funding will allow Binghamton University to conduct important research that is fundamental to our understanding of neurological diseases and can potentially lead to treatment options for patients,” said Senator Gillibrand. “I will always fight in the Senate to make sure that New York’s universities have the necessary resources to support cutting-edge scientific developments, so they can continue being leaders in the health sciences and medical fields.”

The National Institute of General Medical Science (NIGMS) supports biological research, in order to help diagnose, treat, and prevent disease. NIGMS supports scientists and researchers and their efforts to analyze living systems from the molecular and cellular level to humans and populations.